Relmada TherapeuticsRLMD
13F holders, Q3 2025 (September 30)44holders −6
2new positions
8sold out
1famous investor
$2.01avg. 13F price*
At the end of Q3 2025, 44 institutions reported holding Relmada Therapeutics Inc. (RLMD) in their 13F filings, down 6 from Q2 2025. 2 opened new positions and 8 sold out. The largest holders were Ikarian Capital, LLC ($3.7M), Driehaus Capital Management LLC ($1.5M) and Boothbay Fund Management, LLC ($1.4M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Relmada Therapeutics Inc.
- CUSIP
- 75955J402
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1.4M |
| Exits | 8 | $158K |
All 13F filers, Q2 2025 → Q3 2025: 2,921,287 shares bought and 484,860 shares sold, net +2,436,427 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 44 holders
| Ikarian Capital, LLC | 0.75% | Add +4476.8% | 1,843,060 | $3.7M |
| Driehaus Capital Management LLC | 0.01% | No change | 740,006 | $1.5M |
| Boothbay Fund Management, LLC | 0.04% | New | 693,236 | $1.4M |
| Acadian Asset Management LLC | 0.00% | Reduce -6.0% | 582,543 | $1.2M |
| BlackRock, Inc. | 0.00% | No change | 508,000 | $1.0M |
| Vanguard Group Inc. | 0.00% | Add +15.0% | 418,580 | $841K |
| AdvisorShares Investments LLC | 0.13% | Add +1.8% | 403,488 | $811K |
| Geode Capital Management, LLC | 0.00% | Reduce -2.0% | 296,215 | $596K |
| Marshall Wace, LLP | 0.00% | Add +76.0% | 272,053 | $547K |
| Deutsche Bank AG | 0.00% | No change | 224,846 | $452K |
| Corient Private Wealth LP | 0.00% | No change | 206,667 | $402K |
| Two Sigma Investments, LP | 0.00% | Add +82.0% | 173,614 | $349K |
| Renaissance Technologies | 0.00% | Add +13.1% | 169,700 | $341K |
| Parsons Capital Management Inc. | 0.02% | No change | 163,336 | $328K |
| RBF Capital, LLC | 0.02% | No change | 163,261 | $328K |
| Susquehanna International Group, LLP | 0.00% | Add +110.4% | 138,424 | $278K |
| State Street Corp. | 0.00% | Reduce -4.6% | 101,820 | $205K |
| Mgo One Seven LLC | 0.00% | No change | 100,000 | $201K |
| Jane Street Group, LLC | 0.00% | Reduce -25.1% | 85,667 | $172K |
| UBS Group AG | 0.00% | Reduce -66.9% | 59,785 | $120K |
| Northern Trust Corp. | 0.00% | Reduce -0.9% | 59,023 | $119K |
| LMR Partners LLP | 0.00% | Add +0.9% | 55,600 | $112K |
| Simplex Trading, LLC | 0.00% | Add +2087.1% | 53,082 | $106K |
| apricus wealth, LLC | 0.05% | No change | 47,462 | $95K |
| Two Sigma Advisers, LP | 0.00% | Add +54.6% | 38,800 | $78K |
| AlTi Global, Inc. | 0.00% | No change | 31,975 | $64K |
| Robertson Stephens Wealth Management, LLC | 0.00% | No change | 25,000 | $50K |
| Pandora Wealth, Inc. | 0.02% | No change | 20,000 | $40K |
| Tortoise Investment Management, LLC | 0.00% | Reduce -35.8% | 13,909 | $28K |
| Lido Advisors, LLC | 0.00% | No change | 13,905 | $28K |
| World Investment Advisors | 0.00% | Reduce -50.8% | 10,644 | $21K |
| Bedel Financial Consulting, Inc. | 0.00% | No change | 10,000 | $20K |
| Barclays PLC | 0.00% | Add +999900.0% | 10,000 | $20K |
| American Capital Advisory, LLC | 0.00% | No change | 1,954 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -74.5% | 1,581 | $3K |
| Morgan Stanley | 0.00% | Add +21.9% | 1,039 | $2K |
| Farther Finance Advisors, LLC | 0.00% | New | 838 | $2K |
| Bank of America Corp. | 0.00% | Reduce -18.8% | 263 | $528 |
| SBI Securities Co., Ltd. | 0.00% | No change | 102 | $205 |
| BNP Paribas Financial Markets | 0.00% | Add +6.9% | 93 | $187 |
| Osaic Holdings, Inc. | 0.00% | No change | 5 | $9 |
| Citigroup Inc. | 0.00% | No change | 2 | $4 |
| Front Row Advisors LLC | 0.00% | Reduce -33.3% | 2 | $4 |
| Royal Bank of Canada | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is RLMD's weight in each manager's 13F, not the share of Relmada Therapeutics Inc. the manager owns.